A response to "Association of an EAAT2 polymorphism with higher glutamate concentration in relapsing multiple sclerosis"

Journal of Neuroimmunology

Volumn 203, Issue 1, 2008, Pages 116-117

  Westall, Fred C ^a  

^a Institute for Disease Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EXCITATORY AMINO ACID TRANSPORTER 2; GLUTAMIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AMINO ACID BLOOD LEVEL; AUTOIMMUNE DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; MULTIPLE SCLEROSIS; MUTATION RATE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN TRANSPORT; RECURRENCE RISK; REMISSION;

GLUTAMATE PLASMA MEMBRANE TRANSPORT PROTEINS; GLUTAMIC ACID; HUMANS; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; POLYMORPHISM, GENETIC;

EID: 52949101326     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2008.06.022     Document Type: Letter

References (8)

1. Castro-Bello F., Ramos F., Vivanco F., and Marina-Fiol C. High serum glutamic acid levels in patients with carcinoma of the pancreas. Digestion 14 (1976) 360-363
2. Droege W., Eck H.P., Naeher H., Pekar U., and Daniel V. Abnormal amino acid concentration in the blood of patients with AIDS may contribute to the immunological defect. Biol. Chem. Hoppe Seyler 369 (1988) 143-148
3. Griffin C.M., Chard D.T., Parker G.J., Barker G.J., Thompson A.J., and Miller D.H. The relationship between lesion and normal appearing brain tissue abnormalities in early relapsing remitting multiple sclerosis. J. Neurol. 249 (2002) 193-199
4. Martino G., Consiglio A., Franciotta D.M., Corti A., et al. Tumor necrosis factor alpha and its receptors in relapsing-remitting multiple sclerosis. J. Neurol. Sci. 152 (1997) 51-61
5. Robinson A.B., Westall F.C., and Ellison G. Multiple sclerosis: orthomolecular diagnosis by urine amine measurements. Life Sci. 14 (1974) 1747-1753
6. Stover J.F., Pleines U.E., Morgan-Kossmann M.C., Lowitzsch K., and Kempski O.S. Neurotransmitters in cerebrospinal fluid reflect pathological activity. Eur. J. Clin. Invest. 27 (1997) 1038-1043
7. Westall F.C. Molecular mimicry revisited: gut bacteria and multiple sclerosis. J. Clin. Microbiol. 44 (2006) 2099-2104
8. Westall F.C., Hawkins A., Ellison G.W., and Myers L.W. Abnormal glutamic acid metabolism in multiple sclerosis. J. Neurol. Sci. 47 (1980) 353-364